AMICUS THERAPEUTICS, INC. — Director's Dealing 2020

Dec 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2020-12-01

Reporting Person: Kelly Michael Aaron (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-01	Common Stock	A	8837	$0.00	Acquired	8837	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-01	Stock Options (right to buy)	$22.63	A	14222	Acquired	2030-12-01	Common Stock (14222)	Direct

Footnotes

F1: These restricted stock units (RSUs) vest over a period of four years, with 25% vesting on the first anniversary of the grant and 25% on each anniversary thereafter.

F2: These stock options vest and become exercisable over a period of four years, with 25% vesting on the first anniversary of the grant with the remainder vesting ratably each month thereafter.